Induction of differentiation by 1 -hydroxyvitamin D 5 in T47D human breast cancer cells and its interaction with vitamin D receptors

By Lazzaro G.   Agadir A.   Qing W.   Poria M.   Mehta R.R.   Moriarty R.M.   Das Gupta T.K.   Zhang X.-K.   Mehta R.G.  

European Journal of Cancer, Vol. 36, Iss. 6, 2000-04 ,pp. : 780-786

Elsevier

Access to resources Recommend Favorite

Examining the role of cyclin D1 in breast cancer

By Velasco-Veláázquez Marco A   Li Zhiping   Casimiro Mathew   Loro Emanuele   Homsi Nora   Pestell Richard G  

Future Oncology, Vol. 7, Iss. 6, 2011-06 ,pp. : 753-765

Future Medicine

Access to resources Recommend Favorite

Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression

By Grillo Mary   Bott Matthew   Khandke Neha   McGinnis John   Miranda Miriam   Meyyappan Muthupalaniappan   Rosfjord Edward   Rabindran Sridhar  

Breast Cancer Research and Treatment, Vol. 95, Iss. 2, 2006-01 ,pp. : 185-194

Springer Publishing Company

Access to resources Recommend Favorite

Increase of the therapeutic effect on non-smallcell lung cancer cells with combination treatment of shRNA against Cyclin D1 and Bcl-xL in vitro

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 255-260

Spandidos Publications

Access to resources Recommend Favorite

The 870G>A Polymorphism of the Cyclin D1 Gene is not Associated with Breast Cancer

By Krippl Peter  

Breast Cancer Research and Treatment, Vol. 82, Iss. 3, 2003-01 ,pp. : 165-168

Springer Publishing Company

Access to resources Recommend Favorite